Most Recent Articles by Jody A. Charnow, Editor
In a small study, some men whose cancer progressed while on enzalutamide had a profound PSA response to pembrolizumab.
Study implicates higher consumption of advanced glycation end products through dietary fat.
Assay could cut down on cystoscopies, researchers say.
Largest Asian series to date shows a 5-year biochemical recurrence-free survival rate of 76.4%.
Highest vs lowest quartile of intake is associated with a 40% increased risk.
More Articles by Jody A. Charnow, Editor
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)